Pavlos Msaouel: Grateful to know and follow Jad Chahoud

Pavlos Msaouel, Medical Oncologist in the GU Department at MD Anderson Cancer Center, shared a post by Patrick Hwu on X, adding the following:

“Second, third, and fourth this. Jad Chahoud is both a highly thoughtful clinician scientist and connoisseur of rare and common genitourinary malignancies. Grateful to know and follow him.”

Quoting Patrick Hwu’s post:

“Follow Friday Dr. Jad Chahoud is an oncologist in the Genitourinary Oncology Program Moffitt Cancer Center whose clinical research focuses advanced kidney and penile cancers. Go give him a follow Jad Chahoud!”

Source: Pavlos Msaouel/X and Patrick Hwu/X
.
Dr. Patrick Hwu, MD, currently serves as the President and CEO of Moffitt Cancer Center. With a focus on understanding the dynamics between tumors and the immune system, Dr. Hwu’s research has been pivotal in advancing gene-modified T cell therapy. He notably contributed seminal work on the development of the first chimeric antigen receptor aimed at combating cancer. His research portfolio extends to vaccines, adoptive T-cell therapies, and mechanisms of immune resistance.

Before joining, Dr. Hwu held numerous leadership roles at The University of Texas MD Anderson Cancer Center for over 17 years. Notably, he served as the inaugural Chairman of the Department of Melanoma Medical Oncology in 2003, as well as the Associate Director of the Center for Cancer Immunology Research. Additionally, he chaired the Department of Sarcoma Medical Oncology, demonstrating his commitment to advancing cancer treatment and research.